Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.
Preliminary evaluation of variable compliance joystick for people with multiple sclerosis.
The effect of exercise on depressive symptoms in adults with neurological disorders: A systematic review and meta-analysis.
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
Compare before deciding. Treatment of relapsing-remitting multiple sclerosis.
Cerebrospinal Venous Outflow in Multiple Sclerosis Patients versus Fatigue and/or Depression.
When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists.
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.
Features of Virchow-Robin spaces in newly diagnosed multiple sclerosis patients.
The ethics of placebo controlled clinical trials in NMO - A balance of risks.
Effects of whole body vibration on hormonal & functional indices in patients with multiple sclerosis.
Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder.
Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab.
LC-MS/MS identification of the one-carbon cycle metabolites in human plasma.
Neurological diseases in pregnancy.
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
Acute disseminated encephalomyelitis.
Diagnostic accuracy of neurophysiological criteria for early diagnosis of AIDP: A prospective study.
Fluctuations in appraisal over time in the context of stable versus non-stable health.
A Friend in Need may not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases.
Differential IL-10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction.
Disability in multiple sclerosis: When synaptic long-term potentiation fails.
Corrigendum.
Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures.
Pages
« first
‹ previous
…
405
406
407
408
409
410
411
412
413
…
next ›
last »